Prioritizing Osteoporosis-Associated Candidates Through Multi-Omics Mendelian Randomization, Transcriptomic Modeling, and in vitro Validation
- 1Department of Orthopedics, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China
- 2Department of Orthopedics, Suzhou Hospital Affiliated to Anhui Medical University, Suzhou, Anhui, People’s Republic of China
Abstract
Background: Gut microbiota, immune traits, and circulating metabolites may contribute to skeletal biology. We integrated genetic association analyses, transcriptomic profiling, and cell experiments to prioritize osteoporosis-associated molecular candidates.
Methods: Two-sample Mendelian randomization (MR), gene prioritization, and three GEO datasets comprising 110 samples were integrated. MR estimates were recalculated while retaining outcome-associated instruments, followed by false-discovery-rate correction. Exploratory classifiers and a five-gene nomogram were evaluated internally. Protein expression and osteoclast formation were examined in control and RANKL-treated RAW264.7 cells in three independent experiments per group. Supplementary validation repeated normalization, screening and tuning within training folds.
Results: Among 2,329 IVW tests, the metabolite exposure indexed by GCST90200621 was associated with osteoporosis after multiplicity adjustment (odds ratio 1.296, 95% confidence interval 1.155–1.454; within-domain adjusted P = 0.0135). No colocalization record had PP.H4 above 0.5. The transcriptomic workflow prioritized CCR1, TRMT2A, FADS2, FBXL14, and TTLL12. The original nine-gene RF analysis had an internal test-partition AUC of 0.805. Expression of all five proteins increased during RANKL-induced osteoclastogenesis. Additional nested validation yielded a mean AUC of 0.528; cross-study performance remained limited. Fixed-five-gene ridge sensitivity analysis yielded a mean internal AUC of 0.756, conditional on prior gene selection.
Conclusion: Integrating genetic and transcriptomic analyses with cell experiments prioritized five osteoporosis-associated candidates whose protein expression increased during osteoclast differentiation. These complementary findings provide a focused basis for biological follow-up; predictive and gene-specific functional applications require further validation.
Related
- Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.
- Prioritizing Sarcopenia-Related Genes from Cross-Trait Candidate Regions: Regulatory Variant Mapping and Phenome-Wide Mendelian Randomization
- Synergistic and antagonistic modulation of PI3K-Akt, MAPK, and NF-κB pathways by velvet antler in osteoporosis: an integrated network pharmacology, single-cell transcriptomic, and experimental validation study
- Integrative Transcriptomic and Network Analyses Reveal Common Molecular Signatures and Turmeric‐Derived Common Therapeutic Candidates for Neurological Diseases
- A Batch-Aware, Subject-Grouped Pipeline to Prioritize HIIT-Associated DNA Methylation Candidates with Cross-Cohort Evaluation in Skeletal Muscle
BibTeX
@article{sun2026prioritizing,
title = {{Prioritizing Osteoporosis-Associated Candidates Through Multi-Omics Mendelian Randomization, Transcriptomic Modeling, and in vitro Validation}},
author = {Lixuan Sun and Shiqi Ni and Kangjia Yang and Xingyu Zhu and Jiabo Tang and Hang Shi and Xiaopeng Sun and Hua Ding},
journal = {International Journal of General Medicine},
year = {2026},
month = nov,
doi = {10.2147/ijgm.s630355},
url = {https://doi.org/10.2147/ijgm.s630355},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Prioritizing Osteoporosis-Associated Candidates Through Multi-Omics Mendelian Randomization, Transcriptomic Modeling, and in vitro Validation
AU - Lixuan Sun
AU - Shiqi Ni
AU - Kangjia Yang
AU - Xingyu Zhu
AU - Jiabo Tang
AU - Hang Shi
AU - Xiaopeng Sun
AU - Hua Ding
PY - 2026
DA - 2026/11/02
JO - International Journal of General Medicine
DO - 10.2147/ijgm.s630355
UR - https://doi.org/10.2147/ijgm.s630355
AB - Background: Gut microbiota, immune traits, and circulating metabolites may contribute to skeletal biology. We integrated genetic association analyses, transcriptomic profiling, and cell experiments to prioritize osteoporosis-associated molecular candidates. Methods: Two-sample Mendelian randomization (MR), gene prioritization, and three GEO datasets comprising 110 samples were integrated. MR estimates were recalculated while retaining outcome-associated instruments, followed by false-discovery-rate correction. Exploratory classifiers and a five-gene nomogram were evaluated internally. Protein expression and osteoclast formation were examined in control and RANKL-treated RAW264.7 cells in three independent experiments per group. Supplementary validation repeated normalization, screening and tuning within training folds. Results: Among 2,329 IVW tests, the metabolite exposure indexed by GCST90200621 was associated with osteoporosis after multiplicity adjustment (odds ratio 1.296, 95% confidence interval 1.155–1.454; within-domain adjusted P = 0.0135). No colocalization record had PP.H4 above 0.5. The transcriptomic workflow prioritized CCR1, TRMT2A, FADS2, FBXL14, and TTLL12. The original nine-gene RF analysis had an internal test-partition AUC of 0.805. Expression of all five proteins increased during RANKL-induced osteoclastogenesis. Additional nested validation yielded a mean AUC of 0.528; cross-study performance remained limited. Fixed-five-gene ridge sensitivity analysis yielded a mean internal AUC of 0.756, conditional on prior gene selection. Conclusion: Integrating genetic and transcriptomic analyses with cell experiments prioritized five osteoporosis-associated candidates whose protein expression increased during osteoclast differentiation. These complementary findings provide a focused basis for biological follow-up; predictive and gene-specific functional applications require further validation.
SN - 1178-7074
ER -